Articles by: Timothy Dean

Morgan Gilman (photo by Jon Gilbert Fox)

Grad Student Profile – Morgan Gilman: Embracing Opportunity

Morgan Gilman, a fourth-year graduate student in the McLellan Lab at Geisel, is helping lead efforts to understand how a particular type of protein allows deadly viruses—such as Ebola and RSV (respiratory syncytial virus)—to gain entry into host cells, and how antibodies can be developed to neutralize that process.

Photo: Shutterstock

Study Finds Legal Cannabis Laws Impact Teen Use

A new study by researchers at Dartmouth has found that adolescents living in medical marijuana states with a plethora of dispensaries are more likely to have tried new methods of cannabis use, such as edibles and vaping, at a younger age than those living in states with fewer dispensaries.

Photo: Shutterstock

New Antibody Shows Promise for Preventing RSV in Infants

Thanks to a collaboration between the pharmaceutical company MedImmune and Geisel structural biologist Jason McLellan, PhD, a long-awaited vaccine to protect infants from RSV may soon become a reality. Their findings are featured as this month’s cover story in the journal Science Translational Medicine.

Shawn O'Leary speaks at the Conversations with Changemakers event on Jan. 26. (Photo by Eli Burakian D'00)

O’Leary Receives MLK Social Justice Award

Shawn O’Leary, director of the Office for Diversity, Inclusion and Community Engagement at Geisel, has received the Holly Fell Sateia Award, one of four Martin Luther King Jr. Social Justice Awards given this year as part of the Dartmouth community’s month-long celebration honoring the life and legacy of the civil rights leader.

Ambrose Cheung, MD (left) with Stephen Costa (right), a third-year graduate student in his lab. (photo by Jon Gilbert Fox)

Ambrose Cheung Receives National Scholar-Innovator Award

Dartmouth researcher Ambrose Cheung, MD, has received a 2017 Harrington Scholar-Innovator Award, one of only a few given annually to top physician-scientists in the U.S. The award will support Cheung’s promising research to develop a vaccine or drug to combat MRSA—virulent staph bacteria causing infections that are increasingly resistant to antibiotics.